Timothy C Thompson

8PUBLICATIONS
41CO-AUTHORS
Cancer cell biologyMolecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.

Chuandong Geng, Man-Chao Zhang, Ganiraju C Manyam

|Apr 07, 2021
Optimizing the diagnosis and management of ductal prostate cancer.

Weranja Ranasinghe, Daniel D Shapiro, Miao Zhang

|Feb 27, 2021
Considering the potential for gene-based therapy in prostate cancer.

Justin R Gregg, Timothy C Thompson

|Aug 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer.

Jody Vykoukal, Johannes F Fahrmann, Justin R Gregg

|May 04, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?

Christopher Logothetis, Ana Aparicio, Timothy C Thompson

Pageof 2